MedPath

Study on acupuncture and moxibustion improving endometrial receptivity of patients with endometrial atypical hyperplasia and endometrial cancer after fertility preserving therapy (1)

Phase 1
Recruiting
Conditions
Endometrial Cancer and Endometrial Atypical Hyperplasia
Registration Number
ITMCTR2100004314
Lead Sponsor
Obstetrics and Gynecology Department, Peking University People's Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

(1) Aged <= 40 years, have strong desire to have children;
(2) atypical hyperplasia of uterus, endometrial cancer progesterone treatment remission;
(3) endometrial cancer iag1-iag2 stage, endometrial atypical hyperplasia;
(4) imaging examination confirmed that the tumor was confined to the endometrium;
(5) estrogen and progesterone receptor (ER, PR) were positive;
(6) peripheral blood CA125 the results showed normal;
(7) no contraindication of progesterone treatment;
(8) evaluation of reproductive function before treatment, no other factors of fertility disorders;
(9) acupuncture treatment to improve endometrial receptivity after retaining reproductive function;
(10) signing informed consent and good follow-up conditions.

Exclusion Criteria

(1) Patients with severe medical diseases and severe impairment of liver and kidney function;
(2) patients with endometrioid adenocarcinoma whose pathological stage or grade is higher than stage IA G1, or with deep myometrial invasion, cervical invasion or distant metastasis in pelvic and abdominal cavity;
(3) patients with drug allergy and contraindications;
(4) patients with other types of endometrial cancer or other malignant tumors of reproductive system; patients with breast cancer or other malignant tumors He can not use progesterone hormone dependent tumor patients;
(5) require hysterectomy or other methods in addition to conservative treatment;
(6) deep vein thrombosis, stroke, myocardial infarction.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Endometrial thickness;
Secondary Outcome Measures
NameTimeMethod
ive birth rate;Egg rate;Relapse free survival;Incidence rate of complications during pregnancy;Endometrial peristalsis;Early spontaneous abortion rate;Anxiety and depression assessment;Preterm birth rate;Available embryo rate;Endometrial morphology;Clinical pregnancy rate;Embryo implantation rate;Recurrence rate;High quality embryo rate;Endometrial blood flow;Pittsburgh sleep quality index;
Âİ Copyright 2025. All Rights Reserved by MedPath